Acute Kidney Injury Among Pediatric Cancer Patients At South Egypt Cancer Institute

NCT06081608 | Unknown

• 1 other identifier: 639
• Study Type: observational
• Target: 2
• Locations: 0 countries
• Sites: N/A

Brief Summary

Cancer is the second most frequent cause of premature death in children. The incidence of pediatric cancer varies by region and country, but it is generally considered rare with an estimated 300,000 new cases diagnosed worldwide. Acute kidney injury in pediatric cancer patients refers to the sudden and often temporary loss of renal function, which can lead to a variety of complications if not treated correctly.

Conditions

To Determine the Cumulative Incidence of AKI Using KDIGO Criteria in Pediatric Patients With Malignancy in South Egypt Cancer Institute (SECI)

Outcome Measures

Primary Outcomes (1)

• To determine the cumulative incidence of AKI using KDIGO criteria in pediatric patients with malignancy in South Egypt Cancer Institute (SECI)

  from November 2023 till November 2024

Interventions

kidney function test DIAGNOSTIC_TEST

blood sample for kidney function test

Eligibility Criteria

• Age: 30 Days - 18 Years
• Sex: all
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Probability Sample

Study Population

•Children of both sexes (aged from 1 month to 18 years at diagnosis)

You may qualify if:

• Children of both sexes (aged from 1 month to 18 years at diagnosis)
• Patients with either hematological malignancies or solid tumors admitted to the Paediatric Oncology and Haematological Malignancies Department

You may not qualify if:

• Children who had an unconfirmed cancer diagnosis.
• Children more than 18 years at diagnosis.
• Children with preexisting chronic kidney disease (CKD) that defined as the presence of structural or functional kidney damage that persist over minimum of three month
• The patient underwent hematopoietic stem cell transplantation. Patients with 1 s.Cr level.
• Patient underwent renal transplant.

Sponsors & Collaborators

• Assiut University: lead

MeSH Terms

Interventions

Kidney Function Tests

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, Urological; Diagnostic Techniques and Procedures; Diagnosis

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Target Duration: 12 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: resident doctor

Study Record Dates

• First Submitted: October 7, 2023
• First Posted: October 13, 2023
• Study Start: November 1, 2023
• Primary Completion: April 1, 2024
• Study Completion: September 1, 2024
• Last Updated: October 13, 2023

Record last verified: 2023-10